OpenAlex
PricingAboutJobs
Log inGet started
Work

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Oncology
DOI: 10.1016/s1470-2045(07)70146-8
Authors: Cesare Gridelli, Ciro Gallo, Anna Ceribelli, Vittorio Gebbia, Teresa Gamucci, Fortunato Ciardiello, Francesco Carozza, Adolfo Favaretto, Bruno Daniele, Domenico Galetta, Santi Barbera, Francesco Rosetti, Antonio Rossi, Paolo Maione, Francesco Cognetti, Antonio Testa, Massimo Di Maio, Alessandro Morabito, Francesco Perrone
Institutions: Azienda Ospedaliera S.Giuseppe Moscati, University of Campania "Luigi Vanvitelli", Instituto Nazionale Tumori Regina Elena, La Maddalena, Istituto Oncologico Veneto, Azienda Ospedaliera G.Rummo
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: green

Funders: Associazione Italiana per la Ricerca sul Cancro, National Institutes of Health, Merck Sharp and Dohme, National Cancer Institute
OpenAlex ID: W2127773617
FWCI: 7.555
Cites: 52
Cited by: 524
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms